You have 9 free searches left this month | for more free features.

Inherited Cancer Gene

Showing 9976 - 10000 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Cervical Cancer, CIN2, CIN3 Trial in Westdene (5 Fluorouracil (5 FU) Cream, Placebo)

Not yet recruiting
  • Cervical Cancer
  • +4 more
  • 5 Fluorouracil (5 FU) Cream
  • Placebo
  • Westdene, Johannesburg, South Africa
    Clinical HIV Research Unit Temba Lethu Wing Helen Joseph Hospita
Nov 30, 2022

NSCLC Trial in Beijing

Not yet recruiting
  • Non-small Cell Lung Cancer
    • Beijing, China
      Peking University People's Hospital
    Apr 23, 2022

    Postoperative Complications Trial in Hefei (totally laparoscopic distal gastrectomy)

    Recruiting
    • Postoperative Complications
    • totally laparoscopic distal gastrectomy
    • Hefei, Other (Non U.s.), China
      Xubing Zhang
    Oct 1, 2022

    Anxiety Trial in Durham (PEACE Program)

    Completed
    • Anxiety
    • PEACE Program
    • Durham, North Carolina
      Duke University Medical Center
    Sep 26, 2022

    Cytotoxic Chemotherapy and PARP Inhibition on Genomic Contexture

    Recruiting
    • Ovarian Cancer
      • Athens, Greece
        Adamantia Nikolaidi
      Aug 9, 2022

      Pancreas Adenocarcinoma Trial in Leiden (Fluorescence-guided surgery using CEA-targeted fluorophore SGM-101)

      Not yet recruiting
      • Pancreas Adenocarcinoma
      • Fluorescence-guided surgery using CEA-targeted fluorophore SGM-101
      • Leiden, Netherlands
        Leiden University Medical Center
      Aug 2, 2023

      Non Small Cell Lung Cancer Trial in Changsha (radiotherapy, Chemotherapy + immunotherapy)

      Not yet recruiting
      • Non Small Cell Lung Cancer
      • radiotherapy
      • Chemotherapy + immunotherapy
      • Changsha, Hunan, China
        Hunan Cancer Hospital
      Oct 17, 2022

      Recurrent Ovarian Cancer Trial in Bochum (chemo with doxorubicin and cisplatin)

      Completed
      • Recurrent Ovarian Cancer
      • chemotherapy with doxorubicin and cisplatin
      • Bochum, NRW, Germany
        Ruhr University Bochum
      Jul 7, 2022

      Pancreatic Cancer and Purtscher-like Retinopathy

      Completed
      • Purtscher Retinopathy
      • Pancreatic Cancer
      • Catania, Italy
        Eva Intagliata
      Apr 23, 2022

      Breast Cancer Lymphedema Trial (Hand Mobility and Grip Strengthening Exercises, Usual Care)

      Not yet recruiting
      • Breast Cancer Lymphedema
      • Hand Mobility and Grip Strengthening Exercises
      • Usual Care
      • (no location specified)
      Aug 5, 2023

      Breast Cancer Trial in Lebanon (Core Exercise Promotion Intervention)

      Completed
      • Breast Cancer
      • Core Exercise Promotion Intervention
      • Lebanon, New Hampshire
        Dartmouth-Hitchcock Health
      Jul 19, 2022

      Refractory Cancer Trial in Hamburg (BIBW 2992 (Afatinib))

      Terminated
      • Refractory Cancer
      • BIBW 2992 (Afatinib)
      • Hamburg, Germany
        University Medical Center Hamburg-Eppendorf
      Jun 29, 2022

      Rectal Cancer Trial in France (64Cu-ATSM)

      Recruiting
      • Rectal Cancer
      • Angers, France
      • +4 more
      Aug 29, 2022

      Frailty in Young Adult Survivors of Childhood Cancer

      Active, not recruiting
      • Acute Lymphoblastic Leukemia
      • +2 more
        • Memphis, Tennessee
          St. Jude Children's Research Hospital
        Jul 8, 2022

        TPExtreme Induced Chemotherapy Followed by Surgery and

        Recruiting
        • Oral Squamous Cell Carcinoma
        • Locally Advanced Head and Neck Squamous Cell Carcinoma
        • Modified radical surgery
        • Radical surgery
        • Changsha, Hunan, China
          Xiangya Hospital, Central South University
        May 14, 2023

        Family Members, Cancer Trial in Birmingham (CASCADE (CAre Supporters Coached to be Adept DEcision partners))

        Recruiting
        • Family Members
        • Cancer
        • CASCADE (CAre Supporters Coached to be Adept DEcision partners)
        • Birmingham, Alabama
        • +1 more
        Dec 14, 2022

        Breast Cancer Trial in Zhengzhou (anlotinib and vinorelbine, Vinorelbine injection)

        Recruiting
        • Breast Cancer
        • anlotinib and vinorelbine
        • Vinorelbine injection
        • Zhengzhou, Henan, China
          Henan Cancer Hospital
        Aug 2, 2022

        Castration-Resistant Prostate Cancer Trial in Worldwide (Apalutamide)

        Active, not recruiting
        • Castration-Resistant Prostate Cancer
        • Greenville, South Carolina
        • +4 more
        Aug 2, 2022

        Advanced Rectal Cancer, Distal Metastasis Trial in Shanghai (a combination therapy)

        Not yet recruiting
        • Advanced Rectal Cancer
        • Distal Metastasis
        • a combination therapy including tislelizumab
        • Shanghai, Shanghai, China
          Xinxiang Li
        Nov 12, 2022

        Brain Cancer, Glioblastoma, Metastatic Cancer Trial in New York (Trastuzumab deruxtecan)

        Recruiting
        • Brain Cancer
        • +4 more
        • Trastuzumab deruxtecan
        • New York, New York
          Memorial Sloan Kettering Cancer Center (All Protocol Activities)
        Sep 22, 2023

        Waldenstrom's Disease, Waldenstrom Macroglobulinemia Trial in Amiens (bone marrow sample, blood sample)

        Recruiting
        • Waldenstrom's Disease
        • Waldenstrom Macroglobulinemia
        • bone marrow sample
        • blood sample
        • Amiens, France
          CHU Amiens
        May 17, 2021

        Prostate Cancer Trial in Beijing (Al18F-PSMA-617, 68Ga-PSMA-617)

        Recruiting
        • Prostate Cancer
        • Beijing, Beijing, China
          Peking Union Medical College Hospital
        May 2, 2023

        Breast Cancer, Castration-resistant Prostate Cancer Trial in Ottawa (Bone modifying agent)

        Recruiting
        • Breast Cancer
        • Castration-resistant Prostate Cancer
        • Bone modifying agent
        • Ottawa, Ontario, Canada
          The Ottawa Hospital Cancer Centre
        Apr 19, 2022

        Gastric or Esophagogastric Junction Adenocarcinoma Trial (nimotuzumab plus paclitaxel, plus paclitaxel)

        Not yet recruiting
        • Gastric or Esophagogastric Junction Adenocarcinoma
        • nimotuzumab plus paclitaxel
        • placebo plus paclitaxel
        • (no location specified)
        Aug 3, 2023